2bal: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="2bal" size="450" color="white" frame="true" align="right" spinBox="true" caption="2bal, resolution 2.10Å" /> '''p38alpha MAP kinase... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2bal.gif|left|200px]]<br /> | [[Image:2bal.gif|left|200px]]<br /><applet load="2bal" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2bal" size=" | |||
caption="2bal, resolution 2.10Å" /> | caption="2bal, resolution 2.10Å" /> | ||
'''p38alpha MAP kinase bound to pyrazoloamine'''<br /> | '''p38alpha MAP kinase bound to pyrazoloamine'''<br /> | ||
==Overview== | ==Overview== | ||
Inhibition of p38alpha MAP kinase is a potential approach for the | Inhibition of p38alpha MAP kinase is a potential approach for the treatment of inflammatory disorders. MKK6-dependent phosphorylation on the activation loop of p38alpha increases its catalytic activity and affinity for ATP. An inhibitor, BIRB796, binds at a site used by the purine moiety of ATP and extends into a "selectivity pocket", which is not used by ATP. It displaces the Asp168-Phe169-Gly170 motif at the start of the activation loop, promoting a "DFG-out" conformation. Some other inhibitors bind only in the purine site, with p38alpha remaining in a "DFG-in" conformation. We now demonstrate that selectivity pocket compounds prevent MKK6-dependent activation of p38alpha in addition to inhibiting catalysis by activated p38alpha. Inhibitors using only the purine site do not prevent MKK6-dependent activation. We present kinetic analyses of seven inhibitors, whose crystal structures as complexes with p38alpha have been determined. This work includes four new crystal structures and a novel assay to measure K(d) for nonactivated p38alpha. Selectivity pocket compounds associate with p38alpha over 30-fold more slowly than purine site compounds, apparently due to low abundance of the DFG-out conformation. At concentrations that inhibit cellular production of an inflammatory cytokine, TNFalpha, selectivity pocket compounds decrease levels of phosphorylated p38alpha and beta. Stabilization of a DFG-out conformation appears to interfere with recognition of p38alpha as a substrate by MKK6. ATP competes less effectively for prevention of activation than for inhibition of catalysis. By binding to a different conformation of the enzyme, compounds that prevent activation offer an alternative approach to modulation of p38alpha. | ||
==About this Structure== | ==About this Structure== | ||
2BAL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with PQA as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http:// | 2BAL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=PQA:'>PQA</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BAL OCA]. | ||
==Reference== | ==Reference== | ||
| Line 17: | Line 16: | ||
[[Category: Breed, J.]] | [[Category: Breed, J.]] | ||
[[Category: Gerhardt, S.]] | [[Category: Gerhardt, S.]] | ||
[[Category: Norman, R | [[Category: Norman, R A.]] | ||
[[Category: Pauptit, R | [[Category: Pauptit, R A.]] | ||
[[Category: Read, J.]] | [[Category: Read, J.]] | ||
[[Category: Tucker, J.]] | [[Category: Tucker, J.]] | ||
| Line 26: | Line 25: | ||
[[Category: serine/threonine kinase]] | [[Category: serine/threonine kinase]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:35:44 2008'' | ||